Ying Liang

Dr. Ying Liang

Hebei Agricultural University, Baoding, Hebei, China

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2022 in Animals
Verified
Journal Article
Open access
PDF file
YLYing Liang
Ying Liang
LWLin Wang
Lin Wang
RZRuipeng Zhang
Ruipeng Zhang
JPJiadi Pan
Jiadi Pan
WWWenhong Wu
Wenhong Wu
RZRenbang Zhao
Renbang Zhao
This paper developed a universal detection method by high-performance liquid chromatography-tandem mass spectrometry to detect three typical clenbuterols, CLB, SAL, and RAC, and to investigate the metabolism of β-agonists in vivo. The parent ions and daughter ions of the three β-receptor agonist standards and the residues in the muscle, liver, and blood samples of rats were obtained by Total Ions Scan mode. The metabolites produced in different tissues at a specific time were qualitatively and quantitatively analyzed, and the corresponding metabolic pathways were inferred. The results showed that the three β-receptor agonists mainly existed in the form of prototype drugs in rats, with a small amount of clenbuterol methyl compound and albuterol methyl compound. There were significant differences in residual metabolism between different tissues of the same species. In addition, different β-receptor agonists have different absorption and utilization rates in rats.